MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more

NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here

VIDEO: MSF's community approach to treating malnutrition in Niger watch it here

WHO's work on the financing of medical research and development is given a fresh start read more

MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more

New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more

Home

Resources

Key Publications

PLoS:Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease.

09 July 2009

MSF has provided diagnostic and treatment services for Chagas disease since 1999. This report describes 10 years of field experience in four MSF programmes in Honduras, Guatemala, and Bolivia, focusing on feasibility protocols, safety of drug therapy, and treatment effectiveness.

Download the report:

Back to list...

To top

Subscribe to our newsletter

CONNECT WITH MSF

Facebook

Twitter

Vimeo

Key publications archives

MSF Campaign for Access to Essential Medicines
Rue de Lausanne 78 - Mailbox 116 - CH-1211 Genève 21
Phone: +41 22 849 84 05 - Fax: +41 22 849 84 04 - access(at)msf.org

contact - sitemap - legal disclaimer

Webdesign & TYPO3 by cobweb

About us

Media Room

Resources

PLoS:Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease.

MSF has provided diagnostic and treatment services for Chagas disease since 1999. This report describes 10 years of field experience in four MSF programmes in Honduras, Guatemala, and Bolivia, focusing on feasibility protocols, safety of drug therapy, and treatment effectiveness.

Key publications archives